Search

Home > GRACEcast Lung Cancer Video > MET-Amplified Lung Cancer: A New Target for XALKORI?
Podcast: GRACEcast Lung Cancer Video
Episode:

MET-Amplified Lung Cancer: A New Target for XALKORI?
Category: Science & Medicine
Duration: 00:07:18
Publish Date: 2014-07-03 14:00:00
Description:

Lung cancer patients with high MET amplification appear to do well on Xalcori (crizotinib), a drug that is approved for ALK positive patients.
Total Play: 0